Martingale Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
48,998
+3,286
| +7% | +$104K | 0.04% | 363 |
|
|
2025
Q1 | $1.52M | Buy |
45,712
+8,113
| +22% | +$269K | 0.04% | 368 |
|
|
2024
Q4 | $1.29M | Buy |
37,599
+2,816
| +8% | +$96.9K | 0.03% | 416 |
|
|
2024
Q3 | $1.39M | Buy |
34,783
+14,946
| +75% | +$598K | 0.03% | 396 |
|
|
2024
Q2 | $598K | Buy |
+19,837
| New | +$598K | 0.01% | 567 |
|
|
2023
Q4 | – | Sell |
-11,240
| Closed | -$368K | – | 814 |
|
|
2023
Q3 | $368K | Hold |
11,240
| – | – | 0.01% | 654 |
|
|
2023
Q2 | $396K | Sell |
11,240
-14,533
| -56% | -$511K | 0.01% | 655 |
|
|
2023
Q1 | $841K | Hold |
25,773
| – | – | 0.02% | 485 |
|
|
2022
Q4 | $1.42M | Buy |
25,773
+196
| +0.8% | +$10.8K | 0.03% | 351 |
|
|
2022
Q3 | $1.13M | Buy |
25,577
+4,755
| +23% | +$211K | 0.02% | 403 |
|
|
2022
Q2 | $1.02M | Buy |
20,822
+799
| +4% | +$39K | 0.02% | 462 |
|
|
2022
Q1 | $975K | Buy |
20,023
+3,302
| +20% | +$161K | 0.01% | 487 |
|
|
2021
Q4 | $713K | Buy |
+16,721
| New | +$713K | 0.01% | 566 |
|